论文部分内容阅读
目的 探讨硫氮 酮对阵发性心房颤动 (房颤 )的治疗效果。方法 选择 6 0例阵发性房颤患者 ,随机分为莫雷西嗪组 30例 ,硫氮酮组 30例 ,随访 3年 ,观察房颤年发作次数 ,持续时间和转变为持续性房颤的情况。结果 硫氮酮可明显减少房颤年发作次数 ,持续时间 (P <0 0 5 )。治疗后与莫雷西嗪组相比 ,两组间差异无显著意义 (P >0 0 5 )。结论 硫氮酮可明显减少阵发性房颤发作次数和持续时间 ,在阻止其转变为持续性房颤也有一定作用
Objective To investigate the therapeutic effect of diazinon on paroxysmal atrial fibrillation (atrial fibrillation). Methods Sixty patients with paroxysmal atrial fibrillation were randomly divided into 30 cases of metoclopramide and 30 cases of thiazide hydrochloride. The patients were followed up for 3 years to observe the number of episodes and the duration of atrial fibrillation episodes Flutter situation. Results Thiazide significantly reduced the frequency and duration of episodes of atrial fibrillation (P <0.05). There was no significant difference between the two groups after treatment (P> 0.05). Conclusion Diltiazem can significantly reduce the number and duration of episodes of paroxysmal atrial fibrillation, and prevent its conversion to persistent atrial fibrillation